T2 Biosystems to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020
February 12 2020 - 4:05PM
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid
detection of sepsis-causing pathogens, announced today that it will
report financial results for the fourth quarter and full year 2019
after market close on Monday, February 24, 2020. Company
management will host a corresponding conference call beginning
at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do
so by dialing 1-877-407-9208 (U.S.) or 1-201-493-6784
(International). A live and archived webcast of the event will be
available at www.t2biosystems.com on the Investors page
in the Events & Presentations section.
About T2 Biosystems:T2 Biosystems, a
leader in the rapid detection of sepsis-causing pathogens, is
dedicated to improving patient care and reducing the cost of care
by helping clinicians effectively treat patients faster than ever
before. T2 Biosystems’ products include the T2Dx® Instrument, the
T2Candida® Panel, the T2Bacteria® Panel, and the
T2Resistance™ Panel and are powered by the proprietary T2
Magnetic Resonance (T2MR®) technology. T2 Biosystems has
an active pipeline of future products, including products for the
detection of additional species and antibiotic resistance markers
of sepsis pathogens, and tests for Lyme disease.
Media Contact: Gina Kent, Vault
Communications gkent@vaultcommunications.com 610-455-2763
Investor Contact: Philip Trip Taylor, Gilmartin
Group philip@gilmartinIR.com 415-937-5406
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Mar 2024 to Apr 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Apr 2023 to Apr 2024